• Leading Cell & Gene Therapy CRO/CDMO
    Gene editing & stem cell technology platforms to advance your immunotherapy, disease modeling, or bioproduction.
    • 15 off-the-shelf iPSC-derived products (NPCs, HPCs) and ready-to-use GMP iPSCs for cell therapy
    • Monoclonal antibody development & in vivo efficacy services with 2,000+ mouse models
    • Unique IP landscape, over 1,000 projects completed, and clients in 47 countries

Home Page

Customizable Services

1,259

Number of Clients

2,219

Completed Projects

47

Countries

12

Years of Experience
ISO 13485 & GMP Ready      NIST Genome Editing Consortium Member

News & Events

Company
Aug 29, 2022

Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy

Milpitas, California, August 29, 2022 -- Applied StemCell, Inc. (ASC), a leading cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry for their needs in developing and manufacturing cell and gene products, today announced...

Read more

Click for more news!

Google